Abstract: The present invention relates to a nutritional composition comprising non-denatured lactoferrin for use in preventing or treating allergy, allergic rhinitis, asthma, urticaria, atopic eczema, allergic conjunctivitis, atopic dermatitis or atopic diseases in an infant or a toddler.

Abstract: The invention relates to nutritional compositions comprising a mixture of non-digestible oligosaccharides comprising short-chain fructo-oligosaccharides, long-chain fructo-oligosaccharides and 2?-fucosyllactose that have been shown to provide a beneficial short-chain fatty acids profile and intestinal bifidobacteria population. The nutritional compositions are for infants and young children and are in particular beneficial for infants or young children suffering from food allergy, in particular cow's milk protein allergy.

Abstract: The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 and one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate for use in the treatment of neurodegenerative diseases and/or neurotrauma, brain injury and/or brain damage. The invention also relates to a composition comprising a combination of DHA, vitamin B2, vitamin D3 with one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate.

Abstract: The present invention provides a process of producing a lactose concentrate, said process comprising the step of subjecting a partially demineralised aqueous lactose isolate to electrodialysis to produce a biotin-reduced lactose isolate containing at least 90% lactose by weight of dry matter and less than 2 mg ash per gram of lactose, and containing: 0.02-1.5 mg sodium per gram of lactose; 0.02-2 mg potassium per gram of lactose; 0.05-1.5 mg chloride per gram of lactose; 0.01-0.25 ?g biotin per gram of lactose. The present invention also relates to a demineralised lactose concentrate having a reduced biotin content that can be produced by the aforementioned process. The invention further relates to an oligosaccharide-enriched biotin-reduced fraction that is obtained when lactose is separated before or after the electrodialysis step.

Abstract: A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening, connected to the collar by a first living hinge. The lid comprises a first lid portion and a second lid portion connected together by a second living hinge which traverses the top surface of the lid and is parallel to the first living hinge. The first lid portion covers the opening. The second lid portion comprises a mating element and the collar comprises a complementary mating element, being configured to engage together to latch the lid to the collar in the closed position of the lid, whereby latching and unlatching of the lid structure is provided by a pivotable motion of the second lid portion about the second living hinge.

Abstract: The invention relates to a composition for use in regulating the autonomic nervous system.

Abstract: The invention relates to the use of beta1,3?-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.

Abstract: The invention relates to compositions comprising EPA, MA and leucine for prevention and/or treatment of a disease or condition involving muscle decline or for improving muscle function.

Abstract: The present invention relates to a nutritional composition for infants and young children comprising a digestible carbohydrate component, wherein the digestible carbohydrate component comprises a mixture of free galactose and at least one digestible carbohydrate selected from the group consisting of maltodextrin and glucose syrup, and with reduced or no lactose and glucose. The invention also relates to the use of the nutritional composition according to the invention for improving body composition or body composition development.

Abstract: The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0° C. and 15° C., (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30-40% compared to the material provided to step (i). The invention also relates to dephosphorylated MPC, MPI or MCI obtainable by the process of the invention, and to a liquid heat-sterilized enteral nutritional composition comprising 2.0-3.

Abstract: The present invention concerns a powdered nutritional composition comprising intact protein and partially hydrolysed whey protein and a dry-blending process for obtaining the powdered nutritional composition.

Abstract: The present invention concerns a powdered nutritional composition comprising dairy protein and plant-based protein with improved organoleptic properties and flowability, a dry-blending process for obtaining the nutritional composition and a method for providing nutrition to a subject comprising administering the nutritional composition. The nutritional compositions according to the invention have an improved flowability index and improved organoleptic properties.

Abstract: A lid structure for a container has an annular collar for attachment to the container. The collar has an opening for providing access to an interior of the container. The lid structure further includes a lid for closing the opening. The lid has an outer periphery and an upper surface with a circumferential ridge located near to but spaced from the outer periphery, whereby a further container having a base diameter can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions dividing the circumferential ridge into at least two ridge portions whereby at least two further containers having the same base diameter can stack partially on the lid.

Abstract: A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter.

Abstract: The invention relates to a nutritional composition comprising a combination of (i) co-enzyme Q10 with (ii) vitamin D and (iii) vitamin B2, for use in the treatment of stroke, preferably ischemic stroke. The invention also relates to a composition comprising a combination of co-enzyme Q10 and vitamin D, and vitamin D3 with optionally polyunsaturated fatty acids selected from DHA, EPA and/or DPA; and/or choline, choline salts and/or choline esters.

Abstract: The present invention is in the field of protein compositions, in particular protein compositions for infant milk formula. The protein compositions according to the invention comprise whey protein, casein and high isoelectric point proteins, such as those having an isoelectric point of at least 6.0. The present invention further relates to the uses of the protein compositions.

Abstract: A method performed by an electronic device assessing a first nutritional composition, obtaining (201, 301, 401) first visual information of the first nutritional composition; determining (202) whether there is a phase separation of the first nutritional composition based on the first visual information; if it is determined that there is a phase separation, determining (203) properties of at least one layer of the phase separation of the first nutritional composition based on the first visual information.

Abstract: The invention relates to the use of beta1,3?-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.

Abstract: The present invention relates to a powdered nutritional composition comprising (i) milk formula particles comprising lipid, protein, digestible carbohydrates, and (ii) human milk oligosaccharide (HMO) particles, wherein the nutritional composition is selected from an infant, follow-on formula and growing up milk, wherein said nutritional composition is not human milk and wherein the lipid in the milk formula particles is in the form of lipid globules, and a. the lipid globules have a mode diameter based on volume of at least 1 ?m, and/or b. at least 40 vol. % of the lipid globules have a diameter of 2 to 12 ?m and wherein the HMO particles comprise at least 2?fucosyllactose (2?FL). The invention also relates to a process to prepare the composition and uses thereof.

Abstract: The present invention concerns nutritional compositions comprising a mixture of non-digestible oligosaccharides consisting of a combination of 5 specific human milk oligosaccharides, beta-galacto-oligosaccharides and long chain fructo-oligosaccharides (lcFOS). The nutritional compositions are of benefit for improving intestinal microbiota.